Showing results (421-430 of 65,595) with videos related to

Sort By:
Pageof 6,560
BMJ Case Reports|April 3, 2024
Atypical presentation of Lemierre's syndrome caused by penicillin-susceptible Staphylococcus aureus in a patient with chronic stomatitis and COVID-19Emma Burgdorf, Janni Jensen, Peter Grimm, et al.
Frontiers in Public Health|July 8, 2026
Effectiveness of a video-based intervention for COVID-19 vaccine acceptance among individuals with mental disorders: a randomized online experimentDaniel Huth, Severin Hennemann, Michael Witthöft, et al.
Disability and Health Journal|November 6, 2018
Correlates of physical activity among children with visual impairmentsAli Brian, Adam Pennell, Pamela Haibach-Beach, et al.
American Journal of Clinical Pathology|May 1, 1992
Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma)H Haibach, T W Burns, H E Carlson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1976
Comparative evaluation of renal transplant rejection with radioiodinated fibrinogen 99mTc-sulfur collid, and 67Ga-citrateE A George, J E Codd, W T Newton, et al.
Biochemistry International|October 1, 1992
Purification and characterization of N-acetyl-alpha-D-galactosaminidase from Gallus domesticusJ Hata, M Dhar, M Mitra, et al.
Biochemical and Biophysical Research Communications|December 31, 1991
Purification and characterization of a Coffea canephora alpha-D-galactosidase isozymeF Haibach, J Hata, M Mitra, et al.
Seminars in Nuclear Medicine|January 29, 2021
How to Design AI-Driven Clinical Trials in Nuclear MedicineGaspar Delso, Davide Cirillo, Joshua D Kaggie, et al.
The British Journal of Radiology|February 11, 2025
18F-FDG PET or PET/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysisOsher N Y Lee, John Kuruvilla, David C Hodgson, et al.
Atherosclerosis|February 1, 1977
Inefficiency of cynarin as therapeutic regimen in familial type II hyperlipoproteinaemiaH Heckers, K Dittmar, F W Schmahl, et al.
Pageof 6,560